MATRIX PROTEINS OF ENVELOPED VIRUSES
MATRIX PROTEINS OF ENVELOPED VIRUSES
批准号:
3131870
负责人:
ROBERT R WAGNER
金额:
$11.02万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-01-01 至 1987-12-31
关键词:
Vesiculovirus calorimetry circular dichroism conformation fluorescence polarization gel electrophoresis genetic manipulation genetic recombination genetic translation membrane lipids membrane structure molecular cloning monoclonal antibody peptides phospholipids temperature sensitive mutant virus assembly virus envelope virus infection mechanism
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The peripheral matrix (M) protein of negative-strand viruses, such as
vesicular stomatitis virus (VSV), plays a key role in virion assembly and
transcription regulation. We propose to characterize the molecular basis
for the membrane binding, nucleocapsid binding, and
transcription-inhibition functions of the VSV M protein by the following
chemical, immunological, genetic, and biophysical methods:
1. Peptides generated by cleavage with specific chemicals and proteases
will be sequenced, mapped, and tested, along with synthetic oligopeptides,
for their capacity to bind to phospholipid vesicles and nucleocapsids, and
to inhibit viral transcription.
2. Monoclonal antibodies to M protein have been prepared and will be tested
for their reactivity with specific peptides and for their capacity to
inhibit the various biological functions of M protein and its peptides.
3. Complementation group III temperature-sensitive mutant M proteins,
restricted in transcription-inhibition, and revertant M proteins will be
tested for their capacity to bind to lipid vesicles, nucleocapsids, and
specific monoclonal antibodies.
4. Recombinant DNA clones of mutant, revertant, and wild-type M-protein
genes will be prepared and their cDNAs sequenced to identify the sites of
lesions in M proteins defective in binding to vesicles and nucleocapsid and
in transcription-inhibition. We eventually hope to prepare cDNA clones of
M genes in expression vectors to make site-directed defective M proteins.
5. Biophysical studies with wild-type and mutant M proteins and their
peptides will be performed to assay perturbations of membrane dynamics
measured by fluorescence depolarization reacting with membranes as
determined by circular dichroism spectroscopy.
6. M proteins of VSV-New Jersey and A/WSN/33 influenza virus and their
monoclonal antibodies will also be examined by these methods for comparison
with the functional and evolutionary relatedness of the M protein of
VSV-Indiana.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Regulation of viral transcription by the matrix protein of vesicular stomatitis virus probed by monoclonal antibodies and temperature-sensitive mutants.
通过单克隆抗体和温度敏感突变体探测水疱性口炎病毒基质蛋白对病毒转录的调节。
DOI:
10.1128/jvi.56.2.386-394.1985
发表时间:
1985
期刊:
Journal of virology
影响因子:
5.4
作者:
[Pal,R, Grinnell,BW, Snyder,RM, Wagner,RR]
通讯作者:
Wagner,RR
Site-specific mutations in vectors that express antigenic and temperature-sensitive phenotypes of the M gene of vesicular stomatitis virus.
表达水泡性口炎病毒 M 基因抗原和温度敏感表型的载体的位点特异性突变。
DOI:
10.1128/jvi.62.10.3729-3737.1988
发表时间:
1988
期刊:
Journal of virology
影响因子:
5.4
作者:
[Li,Y, Luo,LZ, Snyder,RM, Wagner,RR]
通讯作者:
Wagner,RR
Mapping regions of the matrix protein of vesicular stomatitis virus which bind to ribonucleocapsids, liposomes, and monoclonal antibodies.
水疱性口炎病毒基质蛋白与核糖核衣壳、脂质体和单克隆抗体结合的区域图谱。
DOI:
10.1128/jvi.58.3.860-868.1986
发表时间:
1986
期刊:
Journal of virology
影响因子:
5.4
作者:
[Ogden,JR, Pal,R, Wagner,RR]
通讯作者:
Wagner,RR
Point mutations in glycoprotein gene of vesicular stomatitis virus (New Jersey serotype) selected by resistance to neutralization by epitope-specific monoclonal antibodies.
水疱性口炎病毒(新泽西血清型)糖蛋白基因的点突变通过表位特异性单克隆抗体的中和抗性进行选择。
DOI:
10.1016/0042-6822(88)90274-7
发表时间:
1988
期刊:
Virology
影响因子:
3.7
作者:
[Luo,LH, Li,Y, Snyder,RM, Wagner,RR]
通讯作者:
Wagner,RR
Monoclonal antibodies to the glycoprotein of vesicular stomatitis virus (New Jersey serotype): a method for preliminary mapping of epitopes.
水泡性口炎病毒糖蛋白(新泽西血清型)的单克隆抗体:一种初步绘制表位的方法。
DOI:
10.1016/0042-6822(87)90148-6
发表时间:
1987
期刊:
Virology
影响因子:
3.7
作者:
[Bricker,BJ, Snyder,RM, Fox,JW, Volk,WA, Wagner,RR]
通讯作者:
Wagner,RR
共 8 条
CORE--DEVELOPMENT FUNDS
-
批准号:6618868
-
项目类别:
-
资助金额:$7.89万
-
财政年份:2002
-
负责人:ROBERT R WAGNER
-
依托单位:
CORE--DEVELOPMENT FUNDS
-
批准号:6501444
-
项目类别:
-
资助金额:$7.89万
-
财政年份:2001
-
负责人:ROBERT R WAGNER
-
依托单位:
CORE--DEVELOPMENT FUNDS
-
批准号:6352735
-
项目类别:
-
资助金额:$15.27万
-
财政年份:2000
-
负责人:ROBERT R WAGNER
-
依托单位:
CORE--DEVELOPMENT FUNDS
-
批准号:6311505
-
项目类别:
-
资助金额:$15.27万
-
财政年份:2000
-
负责人:ROBERT R WAGNER
-
依托单位:
CORE--DEVELOPMENT FUNDS
-
批准号:6216467
-
项目类别:
-
资助金额:$15.27万
-
财政年份:1999
-
负责人:ROBERT R WAGNER
-
依托单位:
CORE--DEVELOPMENT FUNDS
-
批准号:6102360
-
项目类别:
-
资助金额:$15.27万
-
财政年份:1998
-
负责人:ROBERT R WAGNER
-
依托单位:
CORE--DEVELOPMENT FUNDS
-
批准号:6236881
-
项目类别:
-
资助金额:$15.21万
-
财政年份:1997
-
负责人:ROBERT R WAGNER
-
依托单位:
CANCER RESEARCH CENTER
-
批准号:3101826
-
项目类别:
-
资助金额:$23.95万
-
财政年份:1987
-
负责人:ROBERT R WAGNER
-
依托单位:
CANCER RESEARCH CENTER
-
批准号:3101827
-
项目类别:
-
资助金额:$72.19万
-
财政年份:1987
-
负责人:ROBERT R WAGNER
-
依托单位:
CANCER RESEARCH CENTER
-
批准号:3101825
-
项目类别:
-
资助金额:$64.28万
-
财政年份:1987
-
负责人:ROBERT R WAGNER
-
依托单位:
CANCER RESEARCH CENTER
-
批准号:2091519
-
项目类别:
-
资助金额:$66.56万
-
财政年份:1987
-
负责人:ROBERT R WAGNER
-
依托单位:
CANCER RESEARCH CENTER
-
批准号:3101823
-
项目类别:
-
资助金额:$74.1万
-
财政年份:1987
-
负责人:ROBERT R WAGNER
-
依托单位:
CANCER RESEARCH CENTER
-
批准号:3101828
-
项目类别:
-
资助金额:$70.26万
-
财政年份:1987
-
负责人:ROBERT R WAGNER
-
依托单位:
CANCER RESEARCH CENTER
-
批准号:3101829
-
项目类别:
-
资助金额:$91.06万
-
财政年份:1987
-
负责人:ROBERT R WAGNER
-
依托单位:
MATRIX PROTEINS OF ENVELOPED VIRUSES
-
批准号:3131869
-
项目类别:
-
资助金额:$11.07万
-
财政年份:1985
-
负责人:ROBERT R WAGNER
-
依托单位:
MATRIX PROTEINS OF ENVELOPED VIRUSES
-
批准号:3131867
-
项目类别:
-
资助金额:$10.3万
-
财政年份:1985
-
负责人:ROBERT R WAGNER
-
依托单位:
CELLULAR RESISTANCE TO VIRAL INFECTION
-
批准号:3480580
-
项目类别:
-
资助金额:$29.88万
-
财政年份:1978
-
负责人:ROBERT R WAGNER
-
依托单位:
CELLULAR RESISTANCE TO VIRAL INFECTION
-
批准号:2059765
-
项目类别:
-
资助金额:$33.11万
-
财政年份:1978
-
负责人:ROBERT R WAGNER
-
依托单位:
CELLULAR RESISTANCE TO VIRAL INFECTION
-
批准号:2059764
-
项目类别:
-
资助金额:$31.86万
-
财政年份:1978
-
负责人:ROBERT R WAGNER
-
依托单位:
CELLULAR RESISTANCE TO VIRAL INFECTION
-
批准号:3124891
-
项目类别:
-
资助金额:$29.02万
-
财政年份:1978
-
负责人:ROBERT R WAGNER
-
依托单位:
海外基金